These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34256411)

  • 1. [Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia].
    Leo F; Meybaum C; Wormanns D; Grohé C
    Dtsch Med Wochenschr; 2021 Jul; 146(13-14):927-932. PubMed ID: 34256411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Management of Pulmonary Fibrosis in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2021 Apr; 53(2):233-241. PubMed ID: 34251354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [COVID-19: A Pneumological Point of View - Long-Term Sequelae of COVID-19 - Implications For Follow-up In Respiratory Medicine].
    Leo F; Wormanns D; Grohé C
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1086-1092. PubMed ID: 32731284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19 pneumonia pulmonary fibrosis.
    Tale S; Ghosh S; Meitei SP; Kolli M; Garbhapu AK; Pudi S
    QJM; 2020 Nov; 113(11):837-838. PubMed ID: 32814978
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe acute respiratory failure secondary to acute fibrinous and organizing pneumonia requiring mechanical ventilation: a case report and literature review.
    López-Cuenca S; Morales-García S; Martín-Hita A; Frutos-Vivar F; Fernández-Segoviano P; Esteban A
    Respir Care; 2012 Aug; 57(8):1337-41. PubMed ID: 22348347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications.
    Parra Gordo ML; Weiland GB; García MG; Choperena GA
    Radiologia (Engl Ed); 2021; 63(1):74-88. PubMed ID: 33334590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis.
    Fabbri L; Moss S; Khan FA; Chi W; Xia J; Robinson K; Smyth AR; Jenkins G; Stewart I
    Thorax; 2023 Feb; 78(2):191-201. PubMed ID: 35338102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia.
    Feinstein MB; DeSouza SA; Moreira AL; Stover DE; Heelan RT; Iyriboz TA; Taur Y; Travis WD
    J Clin Pathol; 2015 Jun; 68(6):441-7. PubMed ID: 25742910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and its Mimics: What the Radiologist Needs to Know.
    Hanfi SH; Lalani TK; Saghir A; McIntosh LJ; Lo HS; Kotecha HM
    J Thorac Imaging; 2021 Jan; 36(1):W1-W10. PubMed ID: 32852419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there pulmonary sequelae in patients recovering from COVID-19?
    Rogliani P; Calzetta L; Coppola A; Puxeddu E; Sergiacomi G; D'Amato D; Orlacchio A
    Respir Res; 2020 Oct; 21(1):286. PubMed ID: 33126869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of post-COVID lung parenchymal abnormalities during the three-month follow-up.
    Zubairi ABS; Shaikh A; Zubair SM; Ali AS; Awan S; Irfan M
    Adv Respir Med; 2021; 89(5):477-483. PubMed ID: 34612504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies.
    Ojo AS; Balogun SA; Williams OT; Ojo OS
    Pulm Med; 2020; 2020():6175964. PubMed ID: 32850151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.
    John Wort S; Arachchillage DJ; McCabe C; Price LC
    Respir Med Res; 2020 Nov; 78():100781. PubMed ID: 32889497
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary fibrosis secondary to COVID-19: a narrative review.
    Tanni SE; Fabro AT; de Albuquerque A; Ferreira EVM; Verrastro CGY; Sawamura MVY; Ribeiro SM; Baldi BG
    Expert Rev Respir Med; 2021 Jun; 15(6):791-803. PubMed ID: 33902377
    [No Abstract]   [Full Text] [Related]  

  • 16. [Idiopathic interstitial pneumonia: classification and diagnostic work-up].
    Rochat T; Pache JC
    Rev Med Suisse; 2010 Nov; 6(272):2222-7. PubMed ID: 21207733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
    Wei J; Yang H; Lei P; Fan B; Qiu Y; Zeng B; Yu P; Lv J; Jian Y; Wan C
    J Xray Sci Technol; 2020; 28(3):383-389. PubMed ID: 32474479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
    Kang IS; Kim KJ; Kim Y; Park SH
    Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Ultrasound for Treatment of Patients With COVID-19: Please Report Your Settings and Mechanical Index.
    Rosado-Mendez IM; Smargiassi A; Inchingolo R; Soldati G; Muller M; Demi L
    J Ultrasound Med; 2021 Jan; 40(1):187-189. PubMed ID: 32691856
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the diagnosis and management of nonspecific interstitial pneumonia.
    Drent M; du Bois RM; Poletti V
    Curr Opin Pulm Med; 2003 Sep; 9(5):411-7. PubMed ID: 12904713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.